CD40 expressing B-cells have also been identified within the inflammatory lesions of deceased MS patients, suggesting that the production of antibodies through CD40-mediated T- and B-cell interactions could contribute to MS pathology [42]. This evidence concerns the gene CD40 and myeloid sarcoma.